tiprankstipranks

Cynthia Collins Insider Profile

4 Followers
Cynthia Collins, President & CEO, Director at GenVec Inc, holds 0.00 shares in GenVec Inc (Ticker: GNVC), holds 24.16K shares in Certara (Ticker: CERT), holds 39.30K shares in Poseida Therapeutics (Ticker: PSTX). Most recently, Cynthia Collins ― shares of GenVec Inc on ― for an estimated value of ―.
tipranks
Cynthia Collins

Cynthia Collins
GenVec Inc (GNVC)
President & CEO, Director

Not Ranked
Cynthia Collins has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$746K
47.41%
33.13%
15.01%
4.45%
A breakdown of Cynthia Collins's holdings

Insider Roles

Certara
(CERT)
Director
Editas Medicine
(EDIT)
CEO, Director
Poseida Therapeutics
(PSTX)
Director
DermTech
(DMTK)
Director
Roles that Cynthia Collins holds in companies

Most Profitable Insider Trade

Stock:
Editas Medicine
(EDIT)
Rating:Informative Sell
Date:Aug 21, 2019 - Aug 21, 2020
Return:-39.40%
The most profitable trade made by Cynthia Collins

Cynthia Collins's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
GNVC
GenVec Inc
$0.00
Editas Medicine
Aug 21, 2020
CEO, Director
Uninformative Sell
72.44K
$247.17K
DermTech
Jun 05, 2023
Director
Uninformative Buy
$33.23K
Poseida Therapeutics
Jun 16, 2023
Director
Uninformative Buy
$112.00K
Certara
May 23, 2024
Director
Uninformative Buy
$353.72K
List of latest transactions for each holding click on a transaction to see Cynthia Collins's performance on stock

Cynthia Collins insider profile FAQ

What is the percentage of profitable transactions made by Cynthia Collins?
The percentage of profitable transactions made by Cynthia Collins is ―.
    What is the average return per transaction made by Cynthia Collins?
    The average return per transaction made by Cynthia Collins is ―.
      What stocks does Cynthia Collins hold?
      Cynthia Collins holds: GNVC, EDIT, DMTK, PSTX, CERT stocks.
        What was Cynthia Collins’s latest transaction?
        Cynthia Collins latest transaction was an Uninformative Buy of ―.
          What was Cynthia Collins's most profitable transaction?
          Cynthia Collins’s most profitable transaction was an Informative Sell of EDIT stock on August 21, 2019. The return on the trade was -39.40%.
            What is Cynthia Collins's role in GenVec Inc?
            Cynthia Collins's role in GenVec Inc is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.